Synthetic Implantable Composition with Immunomodulatory Properties
Implantable compositions are based on polymers bearing pendant groups on the polymer backbone functionalized with short chain fatty acid groups, such as one or more of acetate, n-propionate, and n-butyrate by a degradable linkage. Upon a composition being implanted in a subject, such as a human, deg...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
09.11.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Implantable compositions are based on polymers bearing pendant groups on the polymer backbone functionalized with short chain fatty acid groups, such as one or more of acetate, n-propionate, and n-butyrate by a degradable linkage. Upon a composition being implanted in a subject, such as a human, degradation of degradable linkage liberates the short chain fatty acid groups. The liberated short chain fatty acid groups may then participate in biochemical processes in the subject, which may produce a therapeutic benefit such as resolving inflammation, promoting tissue healing, and/or promoting tolerating self-antigens and neoantigens. |
---|---|
Bibliography: | Application Number: US202318142878 |